Detalhe da pesquisa
1.
Higher-dose venetoclax with measurable residual disease-guided azacitidine discontinuation in newly diagnosed acute myeloid leukemia.
Haematologica
; 108(10): 2616-2625, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37051756
2.
NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 3.2022.
J Natl Compr Canc Netw
; 20(2): 106-117, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35130502
3.
Sweet syndrome in patients with and without malignancy: A retrospective analysis of 83 patients from a tertiary academic referral center.
J Am Acad Dermatol
; 78(2): 303-309.e4, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29107342
4.
Rapid fluorescence in situ hybridisation optimises induction therapy for acute myeloid leukaemia.
Br J Haematol
; 191(5): 935-938, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33460058
5.
Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterations.
Blood
; 120(10): 2076-86, 2012 Sep 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-22753872
6.
Advancements and Challenges in the Treatment of AML.
Am Soc Clin Oncol Educ Book
; 44(3): e438662, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38662975
7.
Venetoclax is safe and tolerable as post-transplant maintenance therapy for AML patients at high risk for relapse.
Bone Marrow Transplant
; 58(8): 849-854, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37185614
8.
Myelodysplastic neoplasm-associated U2AF1 mutations induce host defense defects by compromising neutrophil chemotaxis.
Leukemia
; 37(10): 2115-2124, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37591942
9.
A Novel Type of Monocytic Leukemia Stem Cell Revealed by the Clinical Use of Venetoclax-Based Therapy.
Cancer Discov
; 13(9): 2032-2049, 2023 09 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37358260
10.
Aberrant epigenetic and genetic marks are seen in myelodysplastic leukocytes and reveal Dock4 as a candidate pathogenic gene on chromosome 7q.
J Biol Chem
; 286(28): 25211-23, 2011 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21532034
11.
Diurnal variation in mortality in older nocturnal fallers.
Age Ageing
; 41(1): 29-35, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21914664
12.
Venetoclax and azacitidine followed by allogeneic transplant results in excellent outcomes and may improve outcomes versus maintenance therapy among newly diagnosed AML patients older than 60.
Bone Marrow Transplant
; 57(2): 160-166, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34645926
13.
Exposure to biologic therapy and associated maternal and neonatal outcomes in pregnancies complicated by inflammatory bowel disease.
Am J Obstet Gynecol MFM
; 4(1): 100518, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34688951
14.
Machine Learning-Based Exploratory Clinical Decision Support for Newly Diagnosed Patients With Acute Myeloid Leukemia Treated With 7 + 3 Type Chemotherapy or Venetoclax/Azacitidine.
JCO Clin Cancer Inform
; 6: e2200030, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36194842
15.
Systemic mastocytosis in a child with t(8;21) acute myeloid leukemia.
Pediatr Blood Cancer
; 57(4): 684-7, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21671435
16.
The propriety of upgrading responses to venetoclax + azacitidine in newly diagnosed patients with acute myeloid leukemia.
Leuk Lymphoma
; 62(6): 1466-1473, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33375853
17.
Accuracy of third trimester ultrasound in predicting neonatal birthweight in patients with inflammatory bowel disease.
Eur J Obstet Gynecol Reprod Biol
; 264: 336-339, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34375822
18.
Venetoclax and azacitidine compared with induction chemotherapy for newly diagnosed patients with acute myeloid leukemia.
Blood Adv
; 5(24): 5565-5573, 2021 12 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34610123
19.
Histology-specific FGFR2 alterations and FGFR2-TACC2 fusion in mixed adenoid cystic and neuroendocrine small cell carcinoma of the uterine cervix.
Gynecol Oncol Rep
; 34: 100668, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33241100
20.
Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, multicenter, international study.
Leukemia
; 34(12): 3149-3160, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32132655